Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-03
DOI
10.1038/s41409-020-0878-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
- (2018) Partow Kebriaei et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Single Dose Daily Fractionated Is Not Inferior To Twice A Day Fractionated Total Body Irradiation Prior To Allogeneic Stem Cell Transplantation For Acute Leukemia: A Useful Practice Simplification Resulting From The Sarasin Study
- (2018) Yazid Belkacemi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia
- (2017) Nicola Gökbuget et al. HAEMATOLOGICA
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT
- (2017) Gabrielle Roth-Guepin et al. Oncotarget
- Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia
- (2017) Nicola Gökbuget et al. HAEMATOLOGICA
- Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes
- (2017) Abhisek Swaika et al. Cancer Medicine
- Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis
- (2017) Rick Admiraal et al. Lancet Haematology
- Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia
- (2016) Ashley E. Rosko et al. AMERICAN JOURNAL OF HEMATOLOGY
- Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing
- (2016) Moussab Damlaj et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome
- (2016) Federico Lussana et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the
- (2016) Sebastian Giebel et al. CANCER
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT
- (2015) S Nishiwaki et al. BONE MARROW TRANSPLANTATION
- Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT
- (2015) B. N. Savani et al. HAEMATOLOGICA
- Bone Marrow or Peripheral Blood for Reduced-Intensity Conditioning Unrelated Donor Transplantation
- (2015) Mary Eapen et al. JOURNAL OF CLINICAL ONCOLOGY
- Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT
- (2015) B. N. Savani et al. HAEMATOLOGICA
- Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
- (2014) Frédéric Baron et al. CANCER
- Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
- (2014) Sebastian Giebel et al. CANCER
- The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- (2014) Yi Zhou et al. Clinical Lymphoma Myeloma & Leukemia
- Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial
- (2014) Josep-Maria Ribera et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
- (2013) J Tanaka et al. BONE MARROW TRANSPLANTATION
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
- (2013) V Bachanova et al. LEUKEMIA
- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
- (2012) N. Gokbuget et al. BLOOD
- Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia
- (2012) H Pfeifer et al. LEUKEMIA
- Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia
- (2011) R. Ram et al. HAEMATOLOGICA
- Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2010) M. Mohty et al. BLOOD
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission
- (2010) D. I. Marks et al. BLOOD
- Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
- (2009) Anthony S. Stein et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
- (2009) R. Bassan et al. BLOOD
- Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen
- (2009) John M. Storring et al. BRITISH JOURNAL OF HAEMATOLOGY
- Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993
- (2009) Bella Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
- (2009) Françoise Huguet et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study
- (2009) B-S Cho et al. LEUKEMIA
- Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission
- (2008) D. I. Marks et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started